CD40 AND ITS LIGAND - CENTRAL PLAYERS IN B-LYMPHOCYTE SURVIVAL, GROWTH, AND DIFFERENTIATION

被引:50
作者
GORDON, J
机构
[1] Department of Immunology, The Medical School, Birmingham, B15 2TT, Vincent Drive
基金
英国医学研究理事会;
关键词
D O I
10.1016/0268-960X(95)90040-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article brings together information garnered over the last 10 years on the B cell-associated CD40 surface glycoprotein. The discovery in 1992 of a natural counterstructure, the CD40 ligand (CD40L), which can be rapidly induced on T-cells has hastened research and increased interest in this area dramatically. It has become clear that CD40 and its ligand are central players in B cell responses to T-dependent antigens, The capacity of CD40 to deliver signals for B cell growth, differentiation and survival is covered together with discussion of the signal transduction pathways which operate to bring about these changes. Future issues surrounding this important receptor-ligand pair are discussed.
引用
收藏
页码:53 / 56
页数:4
相关论文
共 34 条
[11]   THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY [J].
DURIE, FH ;
FOY, TM ;
MASTERS, SR ;
LAMAN, JD ;
NOELLE, RJ .
IMMUNOLOGY TODAY, 1994, 15 (09) :406-411
[12]   IN-VIVO CD40-GP39 INTERACTIONS ARE ESSENTIAL FOR THYMUS-DEPENDENT HUMORAL IMMUNITY .2. PROLONGED SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY AN ANTIBODY TO THE LIGAND FOR CD40, GP39 [J].
FOY, TM ;
SHEPHERD, DM ;
DURIE, FH ;
ARUFFO, A ;
LEDBETTER, JA ;
NOELLE, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1567-1575
[13]   DEFECTIVE EXPRESSION OF THE CD40 LIGAND IN X-CHROMOSOME-LINKED IMMUNOGLOBULIN DEFICIENCY WITH NORMAL OR ELEVATED IGM [J].
FULEIHAN, R ;
RAMESH, N ;
LOH, R ;
JABARA, H ;
ROSEN, FS ;
CHATILA, T ;
FU, SM ;
STAMENKOVIC, I ;
GEHA, RS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (06) :2170-2173
[14]   SYNERGISTIC INTERACTION BETWEEN INTERLEUKIN-4 AND ANTI-BP50 (CDW40) REVEALED IN A NOVEL B-CELL RESTIMULATION ASSAY [J].
GORDON, J ;
MILLSUM, MJ ;
GUY, GR ;
LEDBETTER, JA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) :1535-1538
[15]  
GORDON J, 1988, J IMMUNOL, V140, P1425
[16]  
GORDON J, 1987, LEUKOCYTE TYPING, V3, P426
[17]  
GORDON J, 1993, FORUM TRENDS EXP CLI, V3, P334
[18]   ANTIBODIES TO MURINE CD40 STIMULATE NORMAL B-LYMPHOCYTES BUT INHIBIT PROLIFERATION OF B LYMPHOMA-CELLS [J].
HEATH, AW ;
CHANG, R ;
HARADA, N ;
SANTOSARGUMEDO, L ;
GORDON, J ;
HANNUM, C ;
CAMPBELL, D ;
SHANAFELT, AB ;
CLARK, EA ;
TORRES, R ;
HOWARD, M .
CELLULAR IMMUNOLOGY, 1993, 152 (02) :468-480
[19]   SUPPRESSION OF APOPTOSIS IN NORMAL AND NEOPLASTIC HUMAN B-LYMPHOCYTES BY CD40 LIGAND IS INDEPENDENT OF BC1-2 INDUCTION [J].
HOLDER, MJ ;
WANG, H ;
MILNER, AE ;
CASAMAYOR, M ;
ARMITAGE, R ;
SPRIGGS, MK ;
FANSLOW, WC ;
MACLENNAN, ICM ;
GREGORY, CD ;
GORDON, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2368-2371
[20]   GROWTH-FACTOR REQUIREMENTS FOR THE STIMULATION OF GERMINAL CENTER B-CELLS - EVIDENCE FOR AN IL-2-DEPENDENT PATHWAY OF DEVELOPMENT [J].
HOLDER, MJ ;
LIU, YJ ;
DEFRANCE, T ;
FLORESROMO, L ;
MACLENNAN, ICM ;
GORDON, J .
INTERNATIONAL IMMUNOLOGY, 1991, 3 (12) :1243-1251